A review of clinical and molecular prognostic factors in osteosarcoma.
about
Methotrexate for high-grade osteosarcoma in children and young adultsMethotrexate for high-grade osteosarcoma in children and young adultsCommon variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.Phase I evaluation of STA-1474, a prodrug of the novel HSP90 inhibitor ganetespib, in dogs with spontaneous cancerThe Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.Experiments and synthesis of bone-targeting epirubicin with the water-soluble macromolecular drug delivery systems of oxidized-dextran.Characterization of STAT3 activation and expression in canine and human osteosarcoma.Expression of survivin detected by immunohistochemistry in the cytoplasm and in the nucleus is associated with prognosis of leiomyosarcoma and synovial sarcoma patients.Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis.Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma.Structuring osteosarcoma knowledge: an osteosarcoma-gene association database based on literature mining and manual annotationCo-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patientsDirect anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours.Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.Biomarkers in Osteosarcoma.Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma.Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in micePostoperative nomogram to predict the probability of metastasis in Enneking stage IIB extremity osteosarcoma.Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.Using epidemiology and genomics to understand osteosarcoma etiology.Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.Osteosarcoma microenvironment: whole-slide imaging and optimized antigen detection overcome major limitations in immunohistochemical quantification.Development of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles.Pre-operative serum C-reactive protein as independent prognostic factor for survival but not infection in patients with high-grade osteosarcoma.Improved survival in osteosarcoma patients with atypical low vascularization.Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modulesView-Angle Tilting and Slice-Encoding Metal Artifact Correction for Artifact Reduction in MRI: Experimental Sequence Optimization for Orthopaedic Tumor Endoprostheses and Clinical ApplicationChicken chorioallantoic membrane as a reliable model to evaluate osteosarcoma-an experimental approach using SaOS2 cell line.Applying Advanced Imaging Techniques to a Murine Model of Orthotopic Osteosarcoma.Serum tumor markers in pediatric osteosarcoma: a summary review.Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastasesSerum CEACAM1 Level Is Associated with Diagnosis and Prognosis in Patients with OsteosarcomaExpression of epidermal growth factor-like domain 7 correlates with clinicopathological features of osteosarcomaPredictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status.Chondroblastic osteosarcoma secondary to fibrosarcoma: A case report and literature reviewDistribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.Invariant NKT cells increase drug-induced osteosarcoma cell death.Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma.
P2860
Q24234472-D4304190-04FE-4673-BD31-A25FE37FCA90Q24241431-4BFC3918-A60A-49F3-9462-05EFC0B4295CQ27851470-16839049-74E9-46FF-9280-EF82F37AA0ADQ28477773-7502F79A-CE50-449F-8C40-1D4DB5E365D8Q30651861-29923B11-212C-41ED-A0EF-ACD997612832Q30729687-74DE2F2D-A02E-4615-A495-3C8AD15804F6Q33417870-0F7F3366-8D86-44C0-AF8E-1FE3513ECC14Q33533999-2A141D15-A68E-4F3F-9E4F-544BA78835C5Q33547651-FB1B5497-0CB2-4185-A8F5-93623C46290AQ33623477-682B4CD3-7D3B-46C9-ADC5-C9BCFE5D7D6BQ33666269-3B13CEE2-7929-41BA-8B68-26B57234444AQ33723658-D45C5350-46CD-4F1B-BB67-97A87F4D751BQ33816168-7A82251C-1A85-44B3-8FC3-6CA95329E221Q33868158-B9FDA6B5-EA3A-4885-A0AA-D43A771ABBC2Q33929072-D657C497-6B9E-41B6-B146-DD99ABF6DA25Q33985880-9B3AC846-AFFE-4147-BEBD-98FFF2B36BEDQ34065323-EB13EEDE-DDC9-4E79-9BD3-13E5781B5AC4Q34090139-B2128741-3BDE-4ABB-8A8C-B9E455B257F8Q34227316-8863FD55-03B5-4CF6-8287-B60CE3AD976DQ34299904-5B6F982B-DD3E-4472-B391-DB5A6A025577Q34332053-974AFB1C-C3C3-4CC3-9EE1-0F388DECF632Q34627943-D0866CE8-B43A-4A63-9A13-4D4B28622CF1Q34631306-6C54AFF3-01C1-422A-A898-E2CDA55F4F45Q35110990-C7323FE9-35ED-4680-A312-8A5F24931E9EQ35172556-C232BE7C-B60F-4EBB-BBA7-B8B4A9C6AECCQ35216187-8E0B67B9-E2C3-46DC-A6B7-E2C41012D417Q35231406-CFD9A6FC-226E-4724-BEE6-86C5CCCB552DQ35301939-70D2DB3B-CEC4-4060-A36F-4DA225D6B99AQ35536576-C314CD1E-7D78-4CB1-BB08-E7A2C55B0DC2Q35775489-78C571B1-DD5E-49EB-A9B9-40FAFAC96266Q35910674-90E0C112-170D-40D8-9692-CB70DE129CF8Q35984687-FF1BF87D-1DE0-4EF1-8BA8-BD5E31ABAD12Q35987375-030B3A0D-C151-4B24-97EF-B0B1E22F11C4Q35988462-3103F539-4824-4738-849D-11C6A282CCF8Q35993067-3A6126FE-8EB4-46B3-A9FE-6523548598D9Q36211310-FFC1CBD5-08FA-487F-B60F-8DB894ACA62CQ36336179-C8ECC67B-56D6-485B-8DB1-23D25708EC86Q36390133-83172EE4-5CE0-40D7-9ECE-185CB4A0EE8EQ36446525-4C5871D6-012E-4C12-942B-A2E047115696Q36475792-07148676-1BB7-42A1-8F48-008B3E1C0971
P2860
A review of clinical and molecular prognostic factors in osteosarcoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A review of clinical and molecular prognostic factors in osteosarcoma.
@en
type
label
A review of clinical and molecular prognostic factors in osteosarcoma.
@en
prefLabel
A review of clinical and molecular prognostic factors in osteosarcoma.
@en
P2093
P1476
A review of clinical and molecular prognostic factors in osteosarcoma.
@en
P2093
Crispin R Dass
Jonathan C M Clark
Peter F M Choong
P2888
P304
P356
10.1007/S00432-007-0330-X
P577
2007-10-27T00:00:00Z